Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Corrigendum to "Safety and efficacy of the COMBO bio-engineered stent in an all-comer PCI cohort: 1-year final clinical outcomes from the MASCOT post-marketing registry" [Int. J. Cardiol. 283 (2019) 67-72].
One-Year COMBO Stent Outcomes in Acute Coronary Syndrome: from the COMBO Collaboration.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
One-Year COMBO Stent Outcomes in Acute Coronary Syndrome: from the COMBO Collaboration.
One-Year COMBO Stent Outcomes in Acute Coronary Syndrome: from the COMBO Collaboration. Cardiovasc Drugs Ther. 2021 04; 35(2):309-320.
View in:
PubMed
subject areas
Acute Coronary Syndrome
Angina, Unstable
Coronary Thrombosis
Drug-Eluting Stents
Endothelial Progenitor Cells
Humans
Myocardial Infarction
Percutaneous Coronary Intervention
Prosthesis Design
Risk Factors
Sirolimus
Time Factors
authors with profiles
Usman Baber